HRTX
Heron Therapeutics Inc.
Company Overview
| Mkt Cap | $182.42M | Price | $1.16 |
| Volume | 1.73M | Change | +1.75% |
| P/E Ratio | -13.4 | Open | $1.15 |
| Revenue | $144.3M | Prev Close | $1.14 |
| Net Income | $-13.6M | 52W Range | $1.04 - $2.68 |
| Div Yield | N/A | Target | $4.75 |
| Overall | 42 | Value | 40 |
| Quality | -- | Technical | 45 |
No chart data available
Stock Overview
Updated DailyHeron Therapeutics Inc. (HRTX) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $1.16 with a market capitalization of $182.42 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows HRTX with a volume of 1.73 million shares. The stock opened up 0.88% from yesterday's close of $1.14. Current analyst estimates project earnings of $-0.04 per share for this year, with next year targeting $-0.02.
HRTX demonstrates weak technical indicators based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including DRRX, ALKS, PCRX, NKTR, LGND.
Key investment considerations for HRTX include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 309.5%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 12:21 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HRTX | $1.16 | +1.8% | 1.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |